SPEAKERS
Distinguished speakers at the First International Symposium on Pediatric Renovascular Hypertension
Anne Marie Cahill, MBBch
Associate Professor of Radiology
Chief, Interventional Radiology
The Children’s Hospital of Philadelphia
Anne Marie Cahill, MBBch, received her medical degree from the University College Galway in Ireland. She currently serves as chief of interventional radiology at the Children’s Hospital of Philadelphia.
She has developed areas of focus within the field of pediatric interventionaI radiology, including, vascular malformation therapy, endovascular therapy of renovascular hypertension and venous thrombolysis.
Dr. Cahill co-directs a vascular malformation clinic at Children’s Hospital of Philadelphia together with Dr. David Low from the Division of Plastic Surgery. This specialty clinic, held monthly, sees a large volume of patient referrals both from local and regional sources. This is a unique state of the art program for the diagnosis and management of pediatric vascular malformations.
As a result of collaboration with all the specialties that manage vascular malformations at CHOP, Dr. Cahill has gained national and international recognition for interventional radiology therapy of vascular malformations. Treating children with complex vascular anomalies poses a great challenge for interventional radiology, yet is one of the most rewarding, she says.
Kyung J. Cho, MD, FACR, FSIR
Dr. Cho is the active Emeritus Professor of Radiology at the University of Michigan Medical School, and has served the Radiology Department, University of Michigan as a Director of Interventional Radiology.
Dr. Cho received his medical degree from Catholic University Medical School in Korea. He has published 163 articles in peer-reviewed journals, given 94 scientific presentations and 153 invited lectures, authored or co-authored 61 book chapters and published two textbooks, “Gastrointestinal Angiography’ and “Carbon Dioxide Angiography.”
Dawn M. Coleman, MD
Handleman Research Professor
Associate Professor of Surgery and Pediatrics & Communicable Diseases
Program Director, Integrated Vascular Surgery Residency and Fellowship
University of Michigan Department of Surgery
Section of Vascular Surgery
Dawn M. Coleman, MD, is an Associate Professor of Surgery and Pediatrics & Communicable Disease at the University of Michigan, where she serves as the Program Director for the Integrated Vascular Residency Program and Fellowship. She graduated with honors from the University of Cincinnati in 1999 and earned her medical degree from the University of Cincinnati’s College of Medicine in 2003. She completed her general surgery residency at the University of Michigan in 2010 and then went on to complete a two-year vascular surgery fellowship at the same institution in 2012.
Dr. Coleman’s clinical interests include the surgical and endovascular management of aneurysmal and occlusive thoracoabdominal aortic and mesenteric vascular disease, and the surgical revascularization of pediatric aortic coarctation and renovascular hypertension. She is the co-director of the University of Michigan’s Renovascular Hypertension Center, and works closely alongside a multidisciplinary group to care for these unique patients.
Her longstanding interest in the management children with developmental aortic coarctation and renovascular hypertension has fueled ongoing translational research interests that focus on the genetic basis of pediatric renovascular hypertension resulting from developmental arterial dysplasia.
Harry Dietz III, MD
Victor A. McKusick Professor of Pediatrics, Institute of Genetic Medicine at Johns Hopkins University School of Medicine
Investigator, Howard Hughes Medical Institute
Dr. Dietz heads a multidisciplinary clinic for the diagnosis and management of individuals with heritable forms of cardiovascular disease, with a special emphasis on Marfan syndrome and related connective tissue disorders. He directs a group of dedicated molecular biologists focused on improvement of the lives of individuals with Marfan syndrome and related disorders through the development of novel diagnostic and treatment strategies.
Dr. Dietz’s research is focused on elucidation of the etiology and pathogenesis of connective tissue disorders that involve the cardiovascular system. Using a human genetics approach, his group identified the genes responsible for multiple syndromic presentations of aortic aneurysm including Marfan syndrome, Loeys-Dietz syndrome and Shprintzen-Goldberg syndrome. His lab is best known for in-depth mechanistic studies that involve the creation and characterization of animal models. This work has firmly implicated the TGF signaling pathway in aneurysm progression and has revealed many unanticipated treatment strategies.
Jonathan R. Dillman, MD, MSc
Jonathan Dillman, MD, MSc is Associate Professor in the Department of Radiology at Cincinnati Children’s Hospital Medical Center, where he also serves as their department’s Associate Chief of Research and the William S. Ball Chair of Radiology Research. He graduated from the Indiana University School of Medicine in 2003 and completed Diagnostic Radiology residency and both pediatric radiology and adult abdominal imaging fellowships at the University of Michigan.
While at the University of Michigan, Dr. Dillmanalso obtained a Master’s of Science degree from the School of public Health. After six years as pediatric radiology faculty in the Department of Radiology at the University of Michigan, he moved to Cincinnati in 2015 to be their Director of Thoracoabdominal Imaging. His clinical and research interests pertain to imaging of the pediatric abdomen, including imaging evaluation of renin-mediated hypertension.
He is on current on the Board of Directors for the Society of Pediatric Radiology, is an exam writer for the American Board of Radiology, and is chair of the American College of Radiology’s Pediatric Quality and Safety Committee.
Jonathan Eliason, MD
Associate Professor of Vascular Surgery, Department of Surgery
Dr. Eliason is the S. Martin Lindenauer Collegiate Professor of Vascular Surgery. He is the 2004 graduate of the vascular fellowship program at the University of Michigan, after which he served as an active duty vascular surgeon in the United States Air Force. He completed one overseas deployment to Balad, Iraq in the 2006-2007 timeframe under Operation Iraqi Freedom.
In 2007, Dr. Eliason returned to the University of Michigan as faculty, where he has focused clinically on open and minimally invasive aortic surgery and pediatric vascular surgery. He has maintained an active research laboratory collaborating with the Department of Defense for the management of non-compressible torso hemorrhage in trauma, and is pursuing basic science research evaluating the effects of tobacco cigarettes and electronic cigarettes on vascular biology and aortic aneurysms.
Dr. Eliason is the immediate Past-President of the Vascular and Endovascular Surgery Society (VESS) and serves in leadership roles at Michigan Medicine as the Co-Director of the Frankel-CVC Multidisciplinary Aortic Program, the Medical Director of the Frankel-CVC’s 5th Floor, and as the Co-Director of the Diagnostic Vascular Unit.
Michael Ferguson, MD
Assistant Professor, Pediatrics, Harvard Medical School
Dr. Ferguson is an Assistant Professor in Pediatrics at Harvard Medical School and an Assistant in Medicine in the Division of Nephrology at Boston Children’s Hospital, where he currently serves as Director of the Renal Hypertension Program and Co-Director of the Center for Midaortic Syndrome and Renovascular Hypertension. In addition to hypertension, Dr. Ferguson’s clinical interests include acute kidney injury, chronic kidney disease, and renal transplantation. He also has a strong interest in medical education and is the Director of the Pediatric Nephrology Fellowship Program.
C. Alberto Figueroa, PhD
Edward B. Diethrich MD Professor in Biomedical Engineering and Vascular Surgery
Dr. Figueroa received his PhD in Mechanical Engineering at Stanford University, where he developed computational methods fluid structure interaction simulation of hemodynamics.
His first academic appointment was a King’s College London in the UK, where he was Senior Lecturer in the Division of Biomedical Engineering and Imaging Sciences.
Dr. Figueroa is currently the Edward B. Diethrich M.D. Professor in Biomedical Engineering and Vascular Surgery at the University of Michigan. His laboratory is focused on three main areas: 1) developing tools for advanced modeling of blood flow. His group develops the modeling software CRIMSON (www.crimson.software); 2) studying the link between abnormal biomechanical stimuli and cardiovascular diseases such as hypertension and thrombosis; 3) simulation-based surgical planning to aid with the optimal planning of cardiovascular surgeries.
Joseph Flynn, MD, MS, FAAP
Joseph Flynn, MD, MS, FAAP, is a Professor of Pediatrics in the University of Washington School of Medicine and Chief of the Division of Nephrology at Seattle Children’s. He also holds the Dr. Robert O. Hickman Endowed Chair in Pediatric Nephrology.
Dr. Flynn completed his pediatric nephrology training at St. Christopher’s Hospital for Children in Philadelphia, PA, and later received an MS in Clinical Research from the Albert Einstein College of Medicine, Bronx, NY.
He is recognized for his specialized expertise in the treatment of childhood hypertension and has led several clinical trials of antihypertensive medications. He also has established an interest in cardiovascular complications of chronic kidney disease in children and is a lead investigator in the NIH-sponsored CKiD cohort study, which focuses on cardiovascular disease in this population. Most recently, Dr. Flynn is leading a study of blood pressure and target organ damage in youth funded by the American heart Association.
Dr. Flynn has served as a research mentor to numerous pediatric nephrology trainees who now hold faculty positions at other academic institutions. Additionally, he has served on the Working Group of the National High Blood Pressure Education Program, the Executive Committee of the AAP Section on Nephrology, is a past-president of the American Society of Pediatric Nephrology and is the co-chair of the American Academy of Pediatrics committee that developed the 2017 AAP clinical practice guideline for childhood hypertension.
Santhi K. Ganesh, MD
Associate Professor – Division of Cardiovascular Medicine, Department of Internal Medicine and Department of Human Genetics.
Dr. Ganesh studies the genetics of cardiovascular diseases and has an interest in both adult and pediatric arterial dysplasia phenotypes. She completed undergraduate and medical school at Northwestern University, after which she trained in Internal Medicine at the University of Michigan and Cardiology fellowship at Johns Hopkins School of Medicine and National Heart Lung and Blood Institute.
Dr. Ganesh completed her postdoctoral research training at the National Heart, Lung and Blood Institute, National Human Genome Research Institute and Johns Hopkins Institute of Genetic Medicine, focused on mechanisms of arterial remodeling and gene discovery for hypertension and other cardiovascular traits and diseases.
Her laboratory at the University of Michigan employs genetic and genomic analysis methods to discover genes and study mechanisms of arterial fibroplasia.
David H. Gutmann, MD, PhD, FAAN
Donald O. Schnuck Family Professor
Vice Chair for Research Affairs
Department of Neurology
Director, Neurofibromatosis (NF) Center
Washington University School of Medicine
Dr. Gutman received his undergraduate, graduate (PhD) and medical (MD) degrees from the University of Michigan, where he trained in immunogenetics in the laboratory of Dr. John Niederhuber. During his residency in Neurology at the University of Pennsylvania, he worked with Dr. Kenneth Fischbeck, who sparked his interest in neurogenetics. He then returned to the University of Michigan for research fellowship training in Human Genetics with Dr. Francis Collins.
During that time, Dr. Gutman he identified the neurofibromatosis type 1 (NF1) protein and began to elucidate its function as a RAS regulator. In late 1993, Dr. Gutmann was recruited to Washington University, becoming a full professor in 2001 and the Donald O. Schnuck Family Professor in 2002. He established the St. Louis Children’s Hospital Neurofibromatosis Clinical Program in 1994 and the Washington University Neurofibromatosis Center in 2004.
His laboratory is currently focused on understanding the genomic, molecular and cellular basis for nervous system problems affecting children and adults with NF1 using both human induced pluripotent stem cells and novel genetically engineered mouse strains. They have used these preclinical models to define the cellular origins of tumors, the contribution of the tumor microenvironment, and the major growth control pathways that dictate brain development in NF. Moreover, the use of NF1 as an experimental model system has revealed numerous insights into the basic neurobiology of human disease, including tumor-stroma dependencies in the cancer ecosystem, the impact of the germline mutation on phenotypic expression, the role of sexual dimorphism in clinical outcome, and the mechanisms underlying cell type-specific, brain region-distinct, and signaling pathway diversity.
Dr. Gutmann has published over 450 peer-reviewed manuscripts, and has been recognized for his achievements with numerous awards, including the 2012 Children’s Tumor Foundation Frederich von Recklinghausen Lifetime Achievement Award, the 2013 Washington University Distinguished Faculty Research Award, the 2014 Riley Church Lectureship, the 2017 Alexander von Humboldt Award, and the 2019 Society for Neuro-Oncology Abhijit Guha Award. He is a Fellow of the American Academy of Neurology, and recently completed his tenure as a member of the National Institute of Neurological Disorders and Stroke Advisory Council.
Dr. Lande’s research program focuses on hypertensive target organ damage in youth, with particular emphasis on the potential effects of hypertension on cognition.
David Kershaw, MD
David Kershaw, MD, has been at Michigan Medicine since 1991 and has been division director of Pediatric Nephrology since 1991. After working in the area of Podocyte biology he has focused on educational, clinical, and administrative endeavors over the past 15 years.
Dr. Kershaw has been on the AAP EQIPP: Hypertension committee, PREP NEPH editor, and International Journal of Nephrology Editorial board. He has published on hypertension prescribing practices, quality improvement, and patient reported outcomes. He is medical director of the Pediatric Kidney Transplant program, runs the pediatric ABPM program, and is a member of the Michigan Medicine Pediatric Vascular Program.
Heung Bae Kim, MD
Heung Bae Kim, MD, is a Professor of Surgery at Harvard Medical School and the Weitzman Family Chair in Surgical Innovation at Boston Children’s Hospital (BCH). He currently serves as the Vice Chair for Clinical Operations in the Department of Surgery and the Director of the Pediatric Transplant Center at BCH.
Born in Korea but raised in Philadelphia, Dr. Kim attended Yale University as an undergraduate and the Albert Einstein College of Medicine before starting his general surgical training at the Hospital of the University of Pennsylvania.
After completing his Pediatric Surgical Fellowship in 2002 at BCH and his Liver Transplant Fellowship at the Lahey Clinic in 2004, he assumed the surgical directorship of both the liver and kidney transplant programs and started the only intestine transplant program in New England, completing the first multivisceral transplant in 2004. Under his leadership, the Pediatric Transplant Center has grown into one of the busiest and most comprehensive pediatric transplant centers in the country.
Marc B. Lande, MD, MPH
Dr. Lande completed pediatric residency at the University of Rochester Medical Center. After serving in the Indian Health Service for 2 years, he completed a fellowship in pediatric nephrology at Boston Children’s Hospital. He returned to Rochester as attending pediatric nephrologist in 2001.
Dr. Lande’s research program focuses on hypertensive target organ damage in youth, with particular emphasis on the potential effects of hypertension on cognition.
Armando J. Lorenzo, MD MSc FRCSC FAAP FACS
Armando Lorenzo was born in Panama City, Panama before moving to the United States for Residency training in Urology. He spent six years in Dallas, completing an ACGME-approved program in Urology at UT Southwestern Medical School. While rotating at Children’s Medical Center he had the opportunity to explore all medical and surgical aspects of Pediatric Urology, which led him to pursue fellowship training in this sub-specialty.
Dr. Lorenzo was granted a fellowship position at the Hospital for Sick Children and the University of Toronto, including a research year in basic science funded by the Urology Care Foundation of the American Urological Association. After completing his fellowship, Armando obtained a Master’s degree in Clinical Epidemiology at the University of Toronto’s HPME program. He became staff pediatric urologist at the Hospital for Sick Children and is now Associate Professor in the Department of Surgery and investigator at the Research Institute.
Lucas Mertens, MD, PhD
Dr. Mertens currently is Section Head Echocardiography at The Hospital for Sick Children in Toronto. He also is an Associate Professor at the University of Toronto.
Dr. Mertens obtained his medical degree at the University of Leuven, Belgium. He earned a doctoral degree in Medical Sciences (Physiology and Molecular Biology) also at the University of Leuven. He trained in Pediatrics and Pediatric Cardiology at the University Hospitals Leuven in Belgium and at The Mayo Clinic in Rochester, MN (USA).
Dr. Mertens worked as a pediatric cardiologist at the University Hospitals in Leuven between 1998 and 2008. His clinical expertise is in pediatric echocardiography. His research interests focus on studying cardiac function in children.
Kevin E. Meyers, MD
Professor of Pediatrics
Assistant Division Chief of Nephrology, Department of Pediatrics
The Children’s Hospital of Philadelphia and University of Pennsylvania
Dr. Meyers is an Attending physician in the Division Nephrology at the Children’s Hospital of Philadelphia (CHOP) and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania (UPENN). He has worked at CHOP/UPENN since 1994.
In addition to serving as Associate Division Chief of Nephrology, Dr. Meyers directs the Division of Nephrology Clinical Services, is the long-time Nephrology Fellowship Training Program Director, and heads the Humanism Program at CHOP. He also has a long-standing interest and commitment to medical education.
Dr. Meyers directs the hypertension (HTN) program and the complex HTN clinic that aims to reduce the risk of cardiovascular disease in children with secondary causes of HTN (CKD, ESKD, TXP, RVHTN etc.). He also works with a dedicated team caring for children and adolescents with Lupus/MCTD.
His research addresses ways to help improve outcomes in children with chronic glomerular disease including nephrotic syndrome and hypertension. He has a particular interest in RVHTN.
Mahendra Moharir MD, MSc, FRACP
Dr. Moharir is a Staff Neurologist and Associate Professor in the Division of Neurology, Department of Pediatrics at the Hospital for Sick Children and University of Toronto, Canada. He is currently the Clinical Director of the Division of Neurology and the Clinical Director of the Stroke Program.
He has strong research interest in pediatric stroke in particular cerebral sinovenous thrombosis, arteriopathies, stroke imaging and stroke outcomes.
Hansel Otero, MD
Dr. Hansel Otero is a diagnostic pediatric radiologist with special research interest in functional MR urography and CT angiography. He is the director of international pediatric radiology education and outreach for the department of radiology at the Children’s Hospital of Philadelphia, assistant professor at the Perelman School of Medicine and Senior Fellow at the Leonard Davis Institute of Health Economics, University of Pennsylvania.
Rulan S. Parekh MD, MS, FRCP(C), FASN
Dr. Rulan Parekh is Associate Chief, Clinical Research, SeniorScientist at the Hospital for Sick Children and University Health Network, and Division Director of Nephrology, Professor of Pediatrics and Medicine in the Departments of Pediatrics, Medicine, Epidemiology at the University of Toronto.
John M. Park MD
Cheng-Yang Chang Professor of Pediatric Urology
Professor, Urology
Chief, Division of Pediatric Urology
Dr. John M. Park graduated from the University of Michigan Medical School in 1990 and completed his urology residency training at the University of Michigan Medical Center in 1995. He was named an American Foundation for Urological Disease MD-Research Scholar and began his laboratory investigative career.
In 1997, Dr. Park went to the Harvard Children’s Hospital in Boston to complete his fellowship training in pediatric urology, developing clinical expertise in complex genitourinary tract reconstructions. Upon returning to the University of Michigan in 1999, he established a NIH-funded laboratory to study the mechanism of kidney and bladder obstruction pathophysiology. He has had a long-standing interest in improving the care of children born with disorders of sex development (DSD), and he has played an integral role in establishing the University of Michigan Clinical Center for DSD. He has also taken a delight in providing charity care to children from around the world with complex urological problems.
Dr. Park has contributed his scholarly work at numerous international, national, and regional meetings and publications, receiving many honors and accolades. His research excellence has been recognized in the form of numerous grants and awards from the National Institute of Health (NIH), Urodynamic Society, American Academy of Pediatrics, Society for Basic Urological Research, and the American Urological Association.
Premal A Patel, BSc, MBBS, MRCS, FRCR
Consultant Paediatric Interventional Radiologist, Great Ormond Street Hospital for Children
Since 2015, Dr Patel has been a Consultant Paediatric Interventional Radiologist at Great Ormond Street Hospital for Children. His clinical practice covers all aspects of paediatric interventional radiology and he has expertise in the management of vascular anomalies, cryoablation and endovascular treatment of renovascular hypertension in children. Dr Patel is currently the lead interventional radiologist for the renovascular hypertension team at Great Ormond Street Hospital.
Dr Patel studied medicine at St Bartholomew’s and The Royal London Hospital School of Medicine and Dentistry, University of London. Following a period of training in Paediatric Surgery in London, Dr Patel undertook training in Clinical Radiology in Southampton. Dr Patel subsequently undertook Fellowships in Paediatric Interventional Radiology at Great Ormond Street Hospital for Children, London, UK and The Hospital for Sick Children (SickKids), University of Toronto, and worked as a Consultant Diagnostic Radiologist at Great Ormond Street Hospital for Children.
Diego Porras, MD
Assistant Professor of Pediatrics, Harvard Medical School
Dr. Porras specializes in Pediatric and Congenital Interventional Cardiology, from the fetus to the adult. He has a special clinical research interest in the interventional management of vasculopathies, including peripheral pulmonary artery stenosis and mid-aortic syndrome.
Dr. Porras is the Chief of the Division of Invasive Cardiology and the co-director of the Mid-Aortic Syndrome and Renovascular Hypertension Center at Boston Children’s Hospital.
Michael Rivkin, MD
Michael Rivkin directs the multidisciplinary Stroke and Cerebrovascular Center at Boston Children’s Hospital, which he founded in 2008.
The program brings together clinicians from child neurology, physiatry, pediatric hematology, neurosurgery, neuroradiology, interventional neuroradiology, emergency medicine, neuropsychology, physical- and occupational therapy for the purpose of providing care for and conducting research on behalf of children who have been beset by stroke and other cerebrovascular disorders.
In addition, he directs the Intensive Care Neurology Consultation Service that provides neurologic consultation to neonatal-, medical-, medical-surgical- and cardiac intensive care units including 250 beds. His research has focused on the response of the developing brain to focal injury using quantitative magnetic resonance imaging tools. The National Institutes of Neurologic Disorders and Stroke, -Child Health and Development, -Mental Health, -Drug Abuse and the Heart Lung and Blood Institute have funded his research. In addition, the Children’s Heart Foundation and the U.S. Department of Education have supported his research group’s work.
Dr. Rivkin and the Stroke and Cerebrovascular Center are active participants in the multinational International Pediatric Stroke Study. Currently, he is Professor of Neurology at Harvard Medical School and holds scientific appointments in the Departments of Psychiatry and Radiology at Boston Children’s Hospital.
Wilhelm Sandmann, MD, PhD
Professor of f Surgery and Vascular Surgery
Dr. Sandmann studied medicine at the German universities of Münster and Kiel, and the Heinrich Heine University of Düsseldorf( HHU). He has had a strong interest in vascular surgery since beginning residency in 1968, where he performed the first carotid artery reconstruction with patchplasty, the first renal artery reconstruction and the first aortic replacement for AAA Between 1970 and 1971. Following additional training in pediatric surgery, cardiac, thoracic and trauma surgery, he became chief of vascular surgery at HHU, and later chief of surgery.
Dr. Sandmann has written and coauthored more than 200 publications, participated in several international textbooks, and edited three books( in German language), one of which was on pediatric vascular diseases. He is an honorary member of numerous European vascular societies( German, Italian, Austrian, Swiss) and also of the Society of Vascular Surgery.
He has trained 60 vascular surgeons , supported 12 for the PhD, and served as Professor of vascular surgery. Since leaving HHU in 2009 he has begun to establish departments of vascular surgery In larger community hospitals, to spread the expertise in and knowledge of vascular diseases and related treatment. Currently he is establishing a vascular surgery department at Evangelisches Krankenhaus in Mettmann, which is an academic teaching hospital of the neighborhood university of Duisburg-Essen.
James C. Stanely, MD
James C. Stanley, MD, is an active Professor Emeritus of Surgery at the University of Michigan, where he was the Head of the Vascular Surgery Section (1976-2004) and a founding Director of the University’s Cardiovascular Center (2003-2014). He had an extensive clinical practice with a major focus on complex aortic disease, pediatric and adult renovascular hypertension, and splanchnic aneurysmal disease. He has had a lifelong interest in vessel pathobiology and was the Director of the Jobst Vascular Research Laboratories (1989-2004).
Dr. Stanley has given more than 700 presentations before clinical and academic societies in the United States and abroad. He was editor of the Journal of Vascular Surgery (1991-1996), and he has authored more than 550 scientific articles and textbook chapters, and edited 15 medical textbooks, including two on renovascular hypertension. He recently authored two personal books, “Boundaries, Coming of Age in Two College Towns” and “Expressions of an Academic Surgeon.”
Kjell Tullus, MD, PhD, FRCPCH
Dr Tullus is a consultant Paediatric Nephrologist at Great Ormond Street Hospital for Children in London.
He graduated at the Karolinska Institute, Stockholm and took his medical training in Stockholm, Sweden where he also made his PhD. He worked as a Paediatrician and Paediatric Nephrologist in Sweden, close to thirty years and in London since 2002.
His main clinical interests are inflammatory diseases like lupus and renal vasculitis, hypertension and UTI. He has tutored five PhD students and authored more than 250 scientific papers and reviews.
Daan H. H. M. Viering, MD, MSc
Daan Viering studied medicine at the Radboud University and graduated cum laude in 2018. He is driven by an interest to understand disease mechanisms.
For one of his internships, he worked at the Royal Free Hospital, University College London together with Detlef Bockenhauer, Robert Kleta and Kjell Tullus to investigate the contribution of genetic factors in renovascular hypertension. Currently, he is finishing this project at the Radboud University medical center as part of his PhD.
Dr. Viering’s PhD work further aims to characterize the effect of mitochondrial disease on salt transport and thus blood pressure, from both a clinical standpoint and a fundamental perspective. With his research that reaches from bench to bedside, he hopes to have an impact on the clinical care for hypertensive patients.
Jillian Warejko, MD
Assistant Professor of Pediatrics (Nephrology)
Associate Program Director Pediatric Nephrology Fellowship, Pediatric Nephrology
Jillian Warejko, MD, is an Assistant Professor of Pediatrics at Yale School of Medicine, where she also serves as associate program director for the pediatric nephrology fellowship. She attended medical school at the University of Rochester and did her residency at St. Louis Children’s Hospital/Washington University in St. Louis. Her fellowship was completed at Boston Children’s Hospital, working in the lab of Friedhelm Hildebrandt.
Dr. Warejko’s research focused at the use of whole exome sequencing in steroid-resistant nephrotic syndrome and mid-aortic syndrome. Currently, she is a clinician educator and continues to integrate exome sequencing into her everyday practice.